Panel & Audience Discussion: What’s Next for Fibrosis? Understanding the Future Directions of the Antifibrotic Field
Time: 3:00 pm
day: Conference Day Two
Details:
This panel brings together experts from across various disease indications to explore the evolving scientific, translational, and clinical landscape of antifibrotic drug development to provide forward-looking perspective on where antifibrotic science is heading, which challenges are most urgent to overcome, and how industry and academia can collaborate more effectively to accelerate progress across diverse indication.
Discussion Topics Include:
- Emerging Key scientific breakthroughs and novel therapeutic targets shaping the future of antifibrotic drug development across multiple organ systems.
- Identify the key translational and clinical challenges hindering progress, including biomarker validation, patient stratification, and trial design optimization
- How emerging antifibrotic therapies can be integrated into existing treatment paradigms and the potential for combination strategies to improve patient outcomes
